CClinicalTrials.gg
CompletedNCT00958789Updated Oct 22, 2021Results posted

Triathlon Total Stabilizer (TS) Outcomes Study

An interventional study of Triathlon TS Knee System in Arthroplasty, Replacement, Knee, sponsored by Stryker Orthopaedics. Completed at 12 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-22.

Sponsored by Stryker Orthopaedics · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study will be a prospective, non-randomized evaluation of the change between preoperative and postoperative outcomes for those receiving the Triathlon® TS Total Knee System for a revision knee operation. The mean total Knee Society Score (for pain, motion and function) change is not 10% worse than, or is superior to, the expected change according to published revision total knee replacement data, for cases implanted with the Triathlon® TS Total Knee System as compared from preoperative to 2 years postoperative.

02

Conditions studied

  • Arthroplasty, Replacement, Knee
03

In context

Lead sponsor

Stryker Orthopaedics is the lead sponsor of 44 studies on the registry; 1 is open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 5 (100%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form.
  • Patient is a male or non-pregnant female age 18 years or older at time of study device implantation.
  • Patient is a candidate for revision of all femoral and tibial components of a total knee replacement.
  • Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

Exclusion Criteria:

  • Patient has a Body Mass Index (BMI) > 40.
  • Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation.
  • Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device.
  • Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration.
  • Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. > 30 days).
  • Patient has a failed unicondylar knee prosthesis.
  • Patient has a known sensitivity to device materials.
  • Patient is a prisoner.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
180 participants (actual)

Study arms

  • Other
    Triathlon TS Knee

    Triathlon TS Knee System

    Device: Triathlon TS Knee System

Interventions

  • DeviceTriathlon TS Knee System

    Total knee replacement for revision cases

06

What researchers measure

Primary outcomes

  1. Knee Society Score (KSS) Change From Preoperative Time Point to 2 Years

    KSS Pain score, KSS Function score, Total Combined KSS The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome. Additionally, the KSS Pain subscore and KSS Function subscore are added together to obtain a total combined score (minimum score 0, maximum score 200).

    Time frame: pre-op, 2 years

Secondary outcomes

  1. Knee Society Score (KSS) Functional Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative

    This outcome measure shows the results of the KSS Functional Score for the groupings of the Joint Line Restoration (JLR). The 2 groups of JLR were stratified by the amount in mm that the joint line was restored to the physiological joint line postoperative. One group was those that were restored to ≤ 5 mm and the other was those that were restored to \> 5mm. The Functional Score of the Knee Society Clinical Rating System ranges from a potential minimum score of 0 to a maximum score of 100 points. It is based on points assigned to ability to walk, climb stairs and the use of ambulatory aids. A higher value represents a better outcome.

    Time frame: 2 years, 5 years

  2. Knee Stability Results Stratified by Joint Line Restoration Groups at 2 and 5 Year Postoperative

    Measures the knee stability results for the groupings of the Joint Line Restoration (JLR). The 2 groups of JLR were stratified by amount in mm that the joint line was restored to physiological joint line postoperative. One group were restored to ≤ 5 mm and the other were restored to \> 5mm. Knee stability is evaluated in the anterior-posterior (AP) and medial-lateral (ML) planes. AP drawer test determines instability in mm of the tibia. It was done in the AP plane in both JLR groupings (≤ 5mm and \> 5mm) at 2 years and 5 years. The AP measurements were sub categorized into 5mm and 5-10mm. ML is tested with a varus valgus stress test to determine any instability as measured in degrees. The ML measurements were done in both JLR groupings (≤ 5mm and \> 5mm) at 2 years and 5 years with all results in only one category of \< 5 degrees. The higher the number of degrees or mm measured the more instability in the knee.

    Time frame: 2 year and 5 year postoperative

  3. Anterior Knee Pain Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative

    Measures the presence or absence of anterior knee pain in the groupings of the Joint Line Restoration (JLR). The 2 groups of JLR were stratified by the amount in mm that the joint line was restored to the physiological joint line postoperative. One group was those that were restored to ≤ 5 mm and the other was those that were restored to \> 5mm. Anterior knee pain is determined by clinical examination with patient and clinician whether it is present or absent.

    Time frame: 2 year and 5 year postoperative

  4. Short Form Health Survey (SF-36) Health Survey Change From Pre-op to Post-op Visits

    The SF-36 Health Survey is a 36-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

    Time frame: pre-op, 1, 2, 5 years

  5. Number of Knees With Radiographic Stability at 1, 2 and 5 Years Postoperative

    The scoring system was based on the Knee Society guidelines and determined by measuring the width of the radiolucent lines for each of the zones of the implant components in millimeters. The total widths are added for each zone which produces a numerical score. Radiolucency in at least 50% of a zone and measuring at least 1 mm in width is defined as radiolucency present. Failure is defined as a score of 10 or greater, regardless of symptoms and considered as radiographic instability.

    Time frame: 1, 2, 5 years

  6. Number of Knees With a Revision of Femoral and/or Tibial Baseplate Component

    Revision was defined as the removal of either the femoral component or the tibial baseplate component.

    Time frame: 5 years

  7. Knee Injury and Osteoarthritis Outcome Score (KOOS) Change From Pre-op to Post-op Visits

    KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

    Time frame: pre-op, 1, 2, 5 years

  8. Hospital Special Surgery (HSS) Patella Score Change From Pre-op to Post-op Visits

    The HSS Patella Score incorporates both subjective symptoms and objective data specific to the patellofemoral joint. It consists of one score from 0-100 with a score of 100 indicating no pain, no functional limitations, no tenderness or crepitus and normal quadriceps strength.

    Time frame: pre-op, 1, 2, 5 years

  9. Lower Extremity Activity Scale (LEAS) Score Change From Pre-op to Post-op Visits

    The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.

    Time frame: pre-op, 1, 2, 5 years

  10. Knee Society Score (KSS) Change From Pre-op to Post-op Visits

    The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.

    Time frame: pre-op, 1,2, 5 year

07

Results

Posted May 19, 2017

Participant flow

Participant flow — Overall Study
MilestoneTriathlon TS Knee
Started180
Completed130
Not completed50
Withdrew: Death5
Withdrew: Lost to follow-up14
Withdrew: Withdrawal by subject17
Withdrew: No 2 yr. knee society score data4
Withdrew: 2 yr. knee society score not calculable1
Withdrew: Subject terminated2
Withdrew: Revision7

Outcome measures

PrimaryKnee Society Score (KSS) Change From Preoperative Time Point to 2 Years

KSS Pain score, KSS Function score, Total Combined KSS The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome. Additionally, the KSS Pain subscore and KSS Function subscore are added together to obtain a total combined score (minimum score 0, maximum score 200).

Time frame:
pre-op, 2 years
Reported as:
Mean · units on a scale
Knee Society Score (KSS) Change From Preoperative Time Point to 2 Years
units on a scaleTriathlon TS Knee
KSS Pain/motion score preoperative39.81 ± 21.12
KSS Pain/motion score 2 yrs.83.97 ± 15.95
KSS Function score preoperative41.43 ± 23.09
KSS Function score 2 yrs.72.90 ± 25.12
Combined KSS score preoperative82.96 ± 34.96
Combined KSS score 2 yrs.157.05 ± 36.13
Statistical analysis
  • Triathlon TS Knee · Mean difference (final values): 70.70
SecondaryKnee Society Score (KSS) Functional Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative

This outcome measure shows the results of the KSS Functional Score for the groupings of the Joint Line Restoration (JLR). The 2 groups of JLR were stratified by the amount in mm that the joint line was restored to the physiological joint line postoperative. One group was those that were restored to ≤ 5 mm and the other was those that were restored to \> 5mm. The Functional Score of the Knee Society Clinical Rating System ranges from a potential minimum score of 0 to a maximum score of 100 points. It is based on points assigned to ability to walk, climb stairs and the use of ambulatory aids. A higher value represents a better outcome.

Time frame:
2 years, 5 years
Reported as:
Mean · units on a scale
Knee Society Score (KSS) Functional Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative
units on a scaleJoint Line Restoration (JLR) ≤ 5 mmJoint Line Restoration (JLR) > 5 mm
KSS Function Score at 2yr75.31 ± 22.8170.00 ± 25.02
KSS Function Score at 5yr66.82 ± 23.3171.36 ± 26.78
SecondaryKnee Stability Results Stratified by Joint Line Restoration Groups at 2 and 5 Year Postoperative

Measures the knee stability results for the groupings of the Joint Line Restoration (JLR). The 2 groups of JLR were stratified by amount in mm that the joint line was restored to physiological joint line postoperative. One group were restored to ≤ 5 mm and the other were restored to \> 5mm. Knee stability is evaluated in the anterior-posterior (AP) and medial-lateral (ML) planes. AP drawer test determines instability in mm of the tibia. It was done in the AP plane in both JLR groupings (≤ 5mm and \> 5mm) at 2 years and 5 years. The AP measurements were sub categorized into 5mm and 5-10mm. ML is tested with a varus valgus stress test to determine any instability as measured in degrees. The ML measurements were done in both JLR groupings (≤ 5mm and \> 5mm) at 2 years and 5 years with all results in only one category of \< 5 degrees. The higher the number of degrees or mm measured the more instability in the knee.

Time frame:
2 year and 5 year postoperative
Reported as:
Number · Knees
Knee Stability Results Stratified by Joint Line Restoration Groups at 2 and 5 Year Postoperative
KneesJoint Line Restoration (JLR) ≤ 5 mmJoint Line Restoration (JLR) > 5mm
Knee Stability AP < 5mm at 2 years4729
Knee Stability AP 5-10mm at 2 years23
Knee Stability AP < 5mm at 5 years3021
Knee Stability AP 5-10mm at 5 years11
Knee Stability ML< 5 degrees at 2 years4932
Knee Stability ML < 5 degrees at 5 years3122
SecondaryAnterior Knee Pain Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative

Measures the presence or absence of anterior knee pain in the groupings of the Joint Line Restoration (JLR). The 2 groups of JLR were stratified by the amount in mm that the joint line was restored to the physiological joint line postoperative. One group was those that were restored to ≤ 5 mm and the other was those that were restored to \> 5mm. Anterior knee pain is determined by clinical examination with patient and clinician whether it is present or absent.

Time frame:
2 year and 5 year postoperative
Reported as:
Number · Knees
Anterior Knee Pain Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative
KneesJoint Line Restoration (JLR) ≤ 5 mmJoint Line Restoration (JLR) > 5 mm
Anterior Knee Pain Absent at 2 yrs4528
Anterior Knee Pain Present at 2 yrs.54
Anterior Knee Pain Absent at 5 yrs.2620
Anterior Knee Pain Present at 5 yrs.72
SecondaryShort Form Health Survey (SF-36) Health Survey Change From Pre-op to Post-op Visits

The SF-36 Health Survey is a 36-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Time frame:
pre-op, 1, 2, 5 years
Reported as:
Mean · units on a scale
Short Form Health Survey (SF-36) Health Survey Change From Pre-op to Post-op Visits
units on a scaleTriathlon TS Knee
SF-36 Physical Score Preoperative32.43 ± 8.07
SF-36 Physical Score 1 year41.30 ± 10.49
SF-36 Physical Score 2 year40.55 ± 11.60
SF-36 Physical Score 5 year38.42 ± 10.44
SF-36 Mental Score Preoperative45.85 ± 14.81
SF-36 Mental Score 1 year52.57 ± 12.33
SF-36 Mental Score 2 year52.42 ± 11.99
SF-36 Mental Score 5 years54.07 ± 11.81
SecondaryNumber of Knees With Radiographic Stability at 1, 2 and 5 Years Postoperative

The scoring system was based on the Knee Society guidelines and determined by measuring the width of the radiolucent lines for each of the zones of the implant components in millimeters. The total widths are added for each zone which produces a numerical score. Radiolucency in at least 50% of a zone and measuring at least 1 mm in width is defined as radiolucency present. Failure is defined as a score of 10 or greater, regardless of symptoms and considered as radiographic instability.

Time frame:
1, 2, 5 years
Reported as:
Number · Knees
Number of Knees With Radiographic Stability at 1, 2 and 5 Years Postoperative
KneesTriathlon TS Knee
Radiographically unstable at 1 year2
Radiographically unstable at 2 year0
Radiographically unstable at 5 year0
SecondaryNumber of Knees With a Revision of Femoral and/or Tibial Baseplate Component

Revision was defined as the removal of either the femoral component or the tibial baseplate component.

Time frame:
5 years
Reported as:
Number · Knees
Number of Knees With a Revision of Femoral and/or Tibial Baseplate Component
KneesTriathlon TS Knee
Aseptic Loosening5
Septic Loosening9
SecondaryKnee Injury and Osteoarthritis Outcome Score (KOOS) Change From Pre-op to Post-op Visits

KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Time frame:
pre-op, 1, 2, 5 years
Reported as:
Mean · units on a scale
Knee Injury and Osteoarthritis Outcome Score (KOOS) Change From Pre-op to Post-op Visits
units on a scaleTriathlon TS Knee
KOOS Pain Preoperative41.51 ± 18.91
KOOS Pain 1 year75.09 ± 21.55
KOOS Pain 2 year74.67 ± 21.36
KOOS Pain 5 year73.95 ± 21.31
KOOS Symptoms Preoperative43.39 ± 18.93
KOOS Symptoms 1 year73.02 ± 21.02
KOOS Symptoms 2 year72.95 ± 19.11
KOOS Symptoms 5 year75.88 ± 17.25
KOOS Daily Living Preoperative45.56 ± 20.41
KOOS Daily Living 1 year76.43 ± 21.19
KOOS Daily Living 2 year76.17 ± 21.83
KOOS Daily Living 5 year74.99 ± 20.34
KOOS Function Sports and Recreational Preoperative12.56 ± 19.95
KOOS Function Sports and Recreational 1 year44.10 ± 34.39
KOOS Function Sports and Recreational 2 year41.86 ± 33.26
KOOS Function Sports and Recreational 5 year42.77 ± 43.41
KOOS Quality of Life Preoperative18.06 ± 17.90
KOOS Quality of Life 1 year55.99 ± 28.20
KOOS Quality of Life 2 year55.74 ± 27.71
KOOS Quality of Life 5 year57.37 ± 27.56
SecondaryHospital Special Surgery (HSS) Patella Score Change From Pre-op to Post-op Visits

The HSS Patella Score incorporates both subjective symptoms and objective data specific to the patellofemoral joint. It consists of one score from 0-100 with a score of 100 indicating no pain, no functional limitations, no tenderness or crepitus and normal quadriceps strength.

Time frame:
pre-op, 1, 2, 5 years
Reported as:
Mean · units on a scale
Hospital Special Surgery (HSS) Patella Score Change From Pre-op to Post-op Visits
units on a scaleTriathlon TS Knee
HSS Patella Score Preoperative45.09 ± 18.43
HSS Patella Score 1 year76.68 ± 21.48
HSS Patella Score 2 year80.08 ± 19.31
HSS Patella Score 5 year78.56 ± 20.24
SecondaryLower Extremity Activity Scale (LEAS) Score Change From Pre-op to Post-op Visits

The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.

Time frame:
pre-op, 1, 2, 5 years
Reported as:
Mean · units on a scale
Lower Extremity Activity Scale (LEAS) Score Change From Pre-op to Post-op Visits
units on a scaleTriathlon TS Knee
LEAS Score Preoperative7.80 ± 2.86
LEAS Score 1 year9.65 ± 3.18
LEAS Score 2 year9.60 ± 3.26
LEAS Score 5 year9.75 ± 3.39
SecondaryKnee Society Score (KSS) Change From Pre-op to Post-op Visits

The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.

Time frame:
pre-op, 1,2, 5 year
Reported as:
Mean · units on a scale
Knee Society Score (KSS) Change From Pre-op to Post-op Visits
units on a scaleTriathlon TS Knee
Pain Motion Mean Preoperative39.81 ± 21.12
Pain Motion Mean 1 year85.45 ± 15.14
Pain Motion Mean 2 year83.97 ± 15.95
Pain Motion Mean 5 year82.06 ± 17.24
Function Mean Preoperative41.43 ± 23.09
Function Mean 1 year74.18 ± 24.00
Function Mean 2 year72.90 ± 25.12
Function Mean 5 year70.71 ± 26.51

Adverse events

Collected over This study requires that all operative site adverse events, regardless of seriousness, and serious systemic adverse events be reported from enrollment through the 5 year postoperative interval. Censored protocol deviations were not included as at risk participants.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Operative Adverse Events0/181 (0%)37/181 (20.4%)59/181 (32.6%)
Non-Operative Adverse Events7/180 (3.9%)40/180 (22.2%)0/180 (0%)
Most frequent serious events
Showing 10 of 22
Most frequent serious events
EventOperative Adverse EventsNon-Operative Adverse Events
Operative SiteMusculoskeletal and connective tissue disorders24/181—
Operative SiteInfections and infestations15/181—
Non-operative SiteCardiac disorders—11/180
Non-operative SiteMusculoskeletal and connective tissue disorders—10/180
Non-operative SiteInfections and infestations—7/180
Non-operative SiteGastrointestinal disorders—5/180
Non-operative SiteRenal and urinary disorders—5/180
Non-operative SiteRespiratory, thoracic and mediastinal disorders—5/180
Non-operative SiteVascular disorders—5/180
Operative SiteInjury, poisoning and procedural complications4/181—
Most frequent other events
Most frequent other events
EventOperative Adverse EventsNon-Operative Adverse Events
Operative SiteMusculoskeletal and connective tissue disorders59/181—

Baseline characteristics

Participants who were censored are not included in baseline analysis.

Age, Continuous
Age, Continuous(years)Triathlon TS Knee
Mean67.25 ± 9.59
Sex: Female, Male
Sex: Female, Male(Participants)Triathlon TS Knee
Female99
Male81
08

Study locations

12 sites
  • The CORE Institute
    Phoenix, Arizona 85023, United States
  • Heekin Institute for Orthopedic Research
    Jacksonville, Florida 32204, United States
  • Midwest Orthopaedics at Rush
    Chicago, Illinois 60612, United States
  • Tufts Medical Center
    Boston, Massachusetts 02111, United States
  • Rothman Institute
    Egg Harbor Township, New Jersey 08234, United States
  • Ridgewood Orthopedics
    Ridgewood, New Jersey 07450, United States
  • Upstate Bone and Joint Center
    East Syracuse, New York 13057, United States
  • University of North Carolina Orthopedics
    Chapel Hill, North Carolina 27599, United States
  • Duke University Medical Center
    Durham, North Carolina 27703, United States
  • Wellington Orthopaedic & Sports Medicine
    Cincinnati, Ohio 45255, United States
  • The Orthopaedic Center
    Tulsa, Oklahoma 74120, United States
  • Scott & White Clinic
    Temple, Texas 76508, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 27, 2013
  • Informed consent form · Apr 28, 2008

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 22, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00958789
Lead sponsor
Stryker Orthopaedics
Responsible party
Sponsor
First posted
Aug 13, 2009
Start date
Jul 2009
Primary completion
Apr 25, 2016
Completion
Mar 28, 2019
Results posted
May 19, 2017
Last update
Oct 22, 2021

Study contacts

Kirby D Hitt, M.D.
study chair · Scott & White Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion